Ololade Adekoya
Psychiatric/Mental Health · Glen Burnie, MDNPI 1144686569
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,394, more than ten times the $15 reported in 2021. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $34.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$901
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$766
- Lundbeck LLC$512
- Axsome Therapeutics, Inc.$432
- Neurocrine Biosciences, Inc.$385
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $1,114 |
| Otsuka America Pharmaceutical, Inc. | 15 | $901 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $766 |
| Lundbeck LLC | 17 | $512 |
| Axsome Therapeutics, Inc. | 14 | $432 |
| Neurocrine Biosciences, Inc. | 6 | $385 |
| Indivior Inc. | 19 | $318 |
| Johnson & Johnson | 2 | $258 |
| Supernus Pharmaceuticals, Inc. | 6 | $198 |
| E.r. Squibb & Sons, L.L.C. | 7 | $184 |
| Corium, LLC | 5 | $113 |
| Biogen | 1 | $107 |
| AstraZeneca | 1 | $97 |
| Alkermes, Inc. | 6 | $96 |
| Bausch Health US, LLC | 3 | $72 |
| TMS Neurohealth Centers Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Neos Therapeutics, LP | 1 | $22 |
| Tris Pharma Inc | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $17 |
| Abbott | 1 | $17 |
| Orexo US, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY ASIMTUFII$389
- VRAYLAR$373
- CAPLYTA$371
- INGREZZA$274
- SPRAVATO$258
- ABILIFY MAINTENA$252
- REXULTI$232
- Auvelity$121
- QELBREE$114
- Zurzuvae$107
How this compares
$5,733 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 13 | $1,496 |
| Quetiapine Fumarate | 45 | $1,037 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $605 |
| Bupropion XlBupropion Hcl | 14 | $396 |
| Mirtazapine | 13 | $167 |
| Buspirone Hcl | 22 | $163 |
| Lamotrigine | 22 | $163 |
| Clonazepam | 16 | $136 |
| Topiramate | 16 | $119 |
| Trazodone Hcl | 12 | $89 |
| Hydroxyzine Hcl | 11 | $80 |
| Fluoxetine Hcl | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Glen Burnie
- Ilya RozenbergGlen Burnie$572K
- Travis BairdGlen Burnie$11K
- Mary Ogunlowo-OmobhudeGlen Burnie$5K
- Hara OyedejiOwings Mills$780K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.